Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma × glofitamab × Clear all

Phase

Phase 2 2 Phase 1 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1

Interventions

Cyclophosphamide 48 Vincristine 46 Doxorubicin 45 Prednisone 37 Rituximab 36 Radiotherapy 30 Etoposide 27 Cytarabine 18 Filgrastim 17 Bleomycin 17 Methotrexate 15 Dexamethasone 12 VAP-cyclo protocol 11 Vinblastine 10 Prednisolone 10 Carmustine 10 Peripheral Blood Stem Cell Transplantation 9 Mitoxantrone 8 Mercaptopurine 8 Melphalan 8 Dacarbazine 8 Leucovorin 7 Lenalidomide 7 ibrutinib 6 Procarbazine 6 Ifosfamide 6 Granulocyte Colony-Stimulating Factor 6 Gemcitabine 6 Hydrocortisone 5 Epoetin Alfa 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084936 2026-03-03

GLOBRYTE

Hoffmann-La Roche

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡